CTRI/2017/03/008162已完成4 期
CLINICAL EVALUATION OF THE TREATMENT OF CLASS II FURCATION INVOLVEMENTS WITH CALCIUM SULFATE HEMIHYDRATE IN NANOPARTICULATE FORM
I0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •the presence of bilateral Class II furcation lesions (according to the classification given by Hamp et al, 1975), with vertical probing depth >5mm and horizontal probing depth >4mm
排除标准
- •exclusion of through and through lesions. Patients with any known medical condition, or on a therapeutic regimen that would decrease the probability of soft tissue or bone healing, pregnant patients, smokers, patients who had undergone periodontal surgery in the last six months or were under any other clinical trial, patients allergic to tetracycline, chlorhexidine and who had any antibiotic medication in the last three months, and those not willing to consent for treatment and subsequent follow-up
研究者
相似试验
已完成
不适用
Evaluation of indirect restorationsClass II caries lesionsCAD/CAM,Ceramic Block,Hybrid Block,Indirect RestorationTCTR20191212002Erciyes University60
进行中（未招募）
不适用
A PHASE II CLINICAL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF DEPOCITE (CITARABINE LIPOSOMIALE INJECTON) FOR THE TREATMENT OF CNS RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPOBLASTIC LEUKEMIA OR VERY RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR VERY AGGRESSIVE LYMPOMACNS RELAPSE IN ADULT PATIENT'S WITH ACUTE LYPHOBLASTIC LEUKEMIA O VERY AGGRESSIVE LYMPHOMAMedDRA version: 6.1Level: HLGTClassification code 10025322EUCTR2004-004082-15-ITAZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)
进行中（未招募）
不适用
A PHASE II CLINICAL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF DEPOCYTE® (CYTARABINE LIPOSOME INJECTION) FOR THE TREATMENT OF CNS RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH-GRADE LYMPHOMA - DepoCyte® in ALL / NHL CNS relapseAcute lymphoblastic leukaemiaEUCTR2005-000173-21-ATDieter Hoelzer, MD,PhD20
进行中（未招募）
1 期
Phase II Trial for the Treatment of Advanced Classical Kaposi?s Sarcoma with the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy - NDpatients with advanced Kaposi sarcoma, stage III/IVMedDRA version: 9.1Level: LLTClassification code 10023287Term: Kaposi's sarcoma classicalEUCTR2007-000567-26-ITISTITUTO SUPERIORE DI SANITA`25
尚未招募
2 期
Comparison of two ayurvedic medicine in the patients suffering from skin diseaseCTRI/2019/10/021747Dr Babasaheb Rangrao Deshmukh